Immacolata Attolico

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis et al. · Blood · 2019 · 99 citations · Full text

Life Sciences, Genetics, Hematology +13

Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma

Immacolata Attolico, Vincenzo Pavone, Angelo Ostuni et al. · Biology of Blood and Marrow Transplantation · 2011 · 73 citations · Full text

Medicine, Hematology, Oncology +17

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese et al. · Hematological Oncology · 2019 · 70 citations · Full text

Medicine, Cardiology, Hematology +16

Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays

Maria Ciccone, Claudio Agostinelli, Gian Matteo Rigolin et al. · Leukemia · 2011 · 69 citations

Veterinary Medicine, Oncology, Pathology +17

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14